XML 381 R30.htm IDEA: XBRL DOCUMENT v3.25.0.1
Insider Trading Arrangements
 3 Months Ended 12 Months Ended
Dec. 31, 2024
shares
Dec. 31, 2024
shares
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement   Our directors and officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) adopted, terminated or modified the Rule 10b5-1 trading arrangements (as defined in Item 408 of Regulation S-K) set forth in the table below. No non-Rule 10b5-1 trading arrangements were adopted, modified or terminated by any director or officer during the period covered by this report.
NameTitleType of Trading ArrangementSecurityActionDate of ActionDuration of Trading ArrangementAggregate Number of Securities Covered
James E. Davis
Chairman, Chief Executive Officer and President
Rule 10b5-1 plan to sellCommon StockAdoption
October 28, 2024
October 28, 2024 to October 28, 2025*
Up to 56,057*
Karthikeyan Kuppusamy
SVP, Clinical Solutions
Rule 10b5-1 plan to sellCommon StockAdoption
October 28, 2024
October 28, 2024 to July 25, 2025*
Up to
2,833*

* Includes shares of common stock to be released from (a) stock options and/or restricted stock units that are expected to vest and/or (b) performance share awards that may vest, subject to the satisfaction of the applicable performance metrics. The actual number of shares of common stock that will be released is not yet determinable and the actual number of shares of common stock that will be sold will be net of the number of shares withheld to satisfy employee tax withholding obligations.
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
James E. Davis [Member]    
Trading Arrangements, by Individual    
Name James E. Davis  
Title Chairman, Chief Executive Officer and President  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date October 28, 2024  
Expiration Date October 28, 2025  
Arrangement Duration 365 days  
Aggregate Available 56,057 56,057
Karthikeyan Kuppusamy [Member]    
Trading Arrangements, by Individual    
Name Karthikeyan Kuppusamy  
Title SVP, Clinical Solutions  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date October 28, 2024  
Expiration Date July 25, 2025  
Arrangement Duration 270 days  
Aggregate Available 2,833 2,833